Search

Search Constraints

You searched for: Author/Creator Davies, Rupert

Search Results

2. Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study. Issue 12 (December 2022)